(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
‘Risk children’s lives for some extra manpower’: IRGC recruits 12 year olds to fill personnel gaps - 2‘Extraordinary’ Iron Age war trumpet uncovered in England
- 3Moving Wedding Objections for Paramount Functions
- 4China’s new condom tax will prove no effective barrier to country’s declining fertility rate
- 5Man Charged for Stealing ‘Incredibly Precious’ 286-Year-Old Violin, Worth More Than $200,000, from a Tavern
- These four astronauts could soon travel farther from Earth than anyone has gone before
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- A few Up-to-date Sacks - Stylish Young ladies Shouldn't Miss
- Could the Star of Bethlehem have actually been a comet?
- Polish law aimed at lowering petrol prices takes effect
- Cyber Monday 2025 streaming deal: Get $42 off six months of Apple TV
- Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- April’s full pink moon will rise in the night sky this week
- 2024 Moving Styles for Kitchen Redesigns
